Skip to content

Study: The effect of PSA on the pCO2

Study: The effect of PSA on the pCO2 - ECOO

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON46065
Enrollment
20
Registered
2019-05-09
Start date
2019-09-02
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

procedurele sedatie en analgesie (PSA) procedurele sedatie en analgesie

Interventions

None listed

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: patients, ASA 1-2, between 18 and 80 years, which are scheduled for a pulmonary vein isolation performed with PSA.

Exclusion criteria

Exclusion criteria: Pregnancy BMI >30 BMI

Design outcomes

Primary

MeasureTime frame
The primary objective of this study is to evaluate the effects of prolonged deep PSA on the arterial CO2.

Secondary

MeasureTime frame
The secondary objective if this study is to evaluate the effects of prolonged deep PSA on the arterial blood gas and pH.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)